AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie balance Sheet — Total assets ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets (DB)
Latest, FY2025
133,960
Period ended Dec 31, 2025
Change on a year earlier
-0.9%
135,161 in FY2024
History
14 years
Since FY2012
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Balance Sheet — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 133,960 | -0.9% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 135,161 | +0.3% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 134,711 | -2.9% | Form 10-K (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 138,805 | -5.3% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 146,529 | -2.7% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 150,565 | +69.0% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 89,115 | +50.1% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 59,352 | -16.2% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 70,786 | +7.1% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 66,099 | +24.6% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 53,050 | +92.8% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 27,513 | -5.8% | Form 10-Q (filed 2015-08-07) ↗ |
| FY2013 | Dec 31, 2013 | 29,198 | +8.1% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 27,008 | – | Form 10-Q (filed 2013-05-08) ↗ |
Breakdown
What makes up balance sheet — total assets ($m)
- Cash and equivalents ($M)5,229 · FY2025
- Accounts receivable, net ($M)12,589 · FY2025
- Inventories ($M)4,951 · FY2025
- Total current assets ($M)29,062 · FY2025
- Property and equipment, net ($M)5,628 · FY2025
- Goodwill ($M)35,640 · FY2025
- Intangible assets, net ($M)52,641 · FY2025
- Accounts payable ($M)34,734 · FY2025
- Total current liabilities ($M)43,289 · FY2025
- Long-term debt and finance lease obligations ($M)58,941 · FY2025
- Retained earnings ($M)-15,493 · FY2025
- Total stockholders' equity (deficit) ($M)-3,228 · FY2025
Cite this data
StockData. (2026). AbbVie Balance Sheet — Total assets ($M) ($M), annual FY2012–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_balance_sheet
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.